Skip to main content
. 2019 Dec 23;42(6):371–380. doi: 10.1016/j.bj.2019.05.005

Fig. 2.

Fig. 2

Immunophenotyping of hTERT-immortalized and non-immortalized primary ACL cells from young and old donors. A strong expression of the surface markers CD44, CD90, CD105, and STRO-1 was observed for immortalized cell-lines and non-immortalized primary ACL-MSCs of young and old donors. Bars indicating 200 μm (primary cells) or 500 μm (cell lines).